Standard Biotools (LAB) Share-based Compensation (2010 - 2026)
Standard Biotools (LAB) posted quarterly Share-based Compensation of $5.0 million for Q1 2026, up 10771.74% year-over-year from N/an in Q1 2025, and up 3.82% quarter-over-quarter from $4.8 million in Q4 2025.
Standard Biotools (LAB) Share-based Compensation (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Share-based Compensation for 17 consecutive years, with $5.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation rose 10771.74% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $22.7 million (up 63.63% YoY), while the FY2025 annual figure was $25.8 million, up 33.54% from the prior year.
- Share-based Compensation climbed to $5.0 million in Q1 2026 per LAB's latest filing, from $4.8 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $7.5 million in Q3 2025 and bottomed at -$9.5 million in Q4 2023.
- Historically, Share-based Compensation has averaged $2.5 million across 5 years, with a median of $3.4 million in 2024.
- Annual changes were most pronounced in 2023 — Share-based Compensation slumped 665.68% — and 2026, when it jumped 10771.74%.
- Standard Biotools' Share-based Compensation stood at $1.7 million in 2022, then plunged by 665.68% to -$9.5 million in 2023, then soared by 160.83% to $5.8 million in 2024, then fell by 16.72% to $4.8 million in 2025, then gained by 3.82% to $5.0 million in 2026.
- Business Quant data shows LAB's Share-based Compensation at $5.0 million in Q1 2026, $4.8 million in Q4 2025, and $7.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.20 Bn | 193.60 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 127.66 Bn | 124.19 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.37 Bn | 32.42 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.89 Bn | 31.78 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Standard Biotools | 253.06 Mn | -223.66 Mn | 10.54 Mn | 4.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.05 Mn |
| Jun 30, 2026 | 4.05 Mn |
| Mar 31, 2026 | 5.00 Mn |
| Mar 31, 2026 | 5.00 Mn |
| Dec 31, 2025 | 4.82 Mn |
| Dec 31, 2025 | 4.82 Mn |
| Sep 30, 2025 | 7.54 Mn |
| Sep 30, 2025 | 7.54 Mn |
| Jun 30, 2025 | 5.37 Mn |
| Jun 30, 2025 | 5.37 Mn |
| Mar 31, 2025 | 46,000.00 |
| Mar 31, 2025 | 46,000.00 |
| Dec 31, 2024 | 5.78 Mn |
| Dec 31, 2024 | 5.78 Mn |
| Sep 30, 2024 | 4.65 Mn |
| Sep 30, 2024 | 4.65 Mn |
| Jun 30, 2024 | 3.41 Mn |
| Jun 30, 2024 | 3.41 Mn |
| Mar 31, 2024 | 17,000.00 |
| Mar 31, 2024 | 17,000.00 |